Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1996 Feb;49(1):M51–M56. doi: 10.1136/mp.49.1.m51

Insulin-like growth factors and IGF binding proteins in cyst fluid from patients with craniopharyngioma prior to intracavitary irradiation with 90Yttrium and thereafter

W Zumkeller 1,2, M Sääf 1,2, T Rähn 1,2
PMCID: PMC408019  PMID: 16696046

Abstract

Aim—To examine a series of cyst fluid samples from patients with craniopharyngioma at various stages of treatment in order to evaluate the use of insulin-like growth factors (IGFs) and IGF binding proteins as tumour markers or indicators of successful treatment, or both.

Methods—Cyst fluid samples were obtained by stereotactic puncture prior to the intracavitary application of 90Yttrium and at subsequent occasions. Analysis was performed by gel chromatography, radio-immunoassays, binding studies, and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) with subsequent western blotting.

Results—IGF-I, -II and IGF binding protein-1 concentrations were measured in three craniopharyngioma cyst fluid samples. Immunoreactive IGF-I and IGF binding protein-1 concentrations in these three samples were between 6 and 29 ng/ml, and 17 and 48 ng/ml, respectively. In contrast, the IGF-II concentrations measured in 19 cyst fluid samples from seven patients with craniopharyngioma at various stages of treatment were much higher at 25-671 ng/ml. SDS-PAGE and subsequent western blotting using [125I]IGF-II as the ligand gave bands with estimated molecular weights of 330, 220, 135, 96, 46, 43, 34, 29, and 13·5 kDa in one adult, and identical bands at 220, 41·5, 37·5, 32, and 19 kDa in three cyst fluid samples from three children with craniopharyngioma.

Conclusions—These results suggest that IGFs and IGF binding proteins are secreted by craniopharyngiomas and that they may alter the growth characteristics of these tumours. Furthermore, the distinct pattern of IGF binding protein sizes might be used as a tool for the differential diagnosis of tumours of the central nervous system.

Keywords: craniopharyngioma

Keywords: insulin-like growth factors

Keywords: IGF binding proteins

Keywords: tumour marker

Full text

PDF
M51

Images in this article

M55Image
on p.M55

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayer-le Lievre C., Ståhlbom P. A., Sara V. R. Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus. Development. 1991 Jan;111(1):105–115. doi: 10.1242/dev.111.1.105. [DOI] [PubMed] [Google Scholar]
  2. Backlund E. O. Studies on craniopharyngiomas. 3. Stereotaxic treatment with intracystic yttrium-90. Acta Chir Scand. 1973;139(3):237–247. [PubMed] [Google Scholar]
  3. Beck F., Samani N. J., Byrne S., Morgan K., Gebhard R., Brammar W. J. Histochemical localization of IGF-I and IGF-II mRNA in the rat between birth and adulthood. Development. 1988 Sep;104(1):29–39. doi: 10.1242/dev.104.1.29. [DOI] [PubMed] [Google Scholar]
  4. Bingas B., Wolter M. Das Kraniopharyngiom. Fortschr Neurol Psychiatr Grenzgeb. 1968 Mar;36(3):117–195. [PubMed] [Google Scholar]
  5. Binoux M., Hossenlopp P., Lassarre C., Hardouin N. Production of insulin-like growth factors and their carrier by rat pituitary gland and brain explants in culture. FEBS Lett. 1981 Feb 23;124(2):178–184. doi: 10.1016/0014-5793(81)80131-7. [DOI] [PubMed] [Google Scholar]
  6. Han V. K., D'Ercole A. J., Lund P. K. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science. 1987 Apr 10;236(4798):193–197. doi: 10.1126/science.3563497. [DOI] [PubMed] [Google Scholar]
  7. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem. 1986 Apr;154(1):138–143. doi: 10.1016/0003-2697(86)90507-5. [DOI] [PubMed] [Google Scholar]
  8. Hynes M. A., Brooks P. J., Van Wyk J. J., Lund P. K. Insulin-like growth factor II messenger ribonucleic acids are synthesized in the choroid plexus of the rat brain. Mol Endocrinol. 1988 Jan;2(1):47–54. doi: 10.1210/mend-2-1-47. [DOI] [PubMed] [Google Scholar]
  9. Lamson G., Pham H., Oh Y., Ocrant I., Schwander J., Rosenfeld R. G. Expression of the BRL-3A insulin-like growth factor binding protein (rBP-30) in the rat central nervous system. Endocrinology. 1989 Aug;125(2):1100–1102. doi: 10.1210/endo-125-2-1100. [DOI] [PubMed] [Google Scholar]
  10. Lund P. K., Moats-Staats B. M., Hynes M. A., Simmons J. G., Jansen M., D'Ercole A. J., Van Wyk J. J. Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem. 1986 Nov 5;261(31):14539–14544. [PubMed] [Google Scholar]
  11. Massagué J., Czech M. P. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem. 1982 May 10;257(9):5038–5045. [PubMed] [Google Scholar]
  12. Ocrant I., Pham H., Oh Y., Rosenfeld R. G. Characterization of insulin-like growth factor binding proteins of cultured rat astroglial and neuronal cells. Biochem Biophys Res Commun. 1989 Mar 31;159(3):1316–1322. doi: 10.1016/0006-291x(89)92254-7. [DOI] [PubMed] [Google Scholar]
  13. Ooi G. T., Orlowski C. C., Brown A. L., Becker R. E., Unterman T. G., Rechler M. M. Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and -2. Mol Endocrinol. 1990 Feb;4(2):321–328. doi: 10.1210/mend-4-2-321. [DOI] [PubMed] [Google Scholar]
  14. Póvoa G., Enberg G., Jörnvall H., Hall K. Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid. Eur J Biochem. 1984 Oct 15;144(2):199–204. doi: 10.1111/j.1432-1033.1984.tb08449.x. [DOI] [PubMed] [Google Scholar]
  15. Sara V. R., Carlsson-Skwirut C., Andersson C., Hall E., Sjögren B., Holmgren A., Jörnvall H. Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4904–4907. doi: 10.1073/pnas.83.13.4904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stylianopoulou F., Efstratiadis A., Herbert J., Pintar J. Pattern of the insulin-like growth factor II gene expression during rat embryogenesis. Development. 1988 Jul;103(3):497–506. doi: 10.1242/dev.103.3.497. [DOI] [PubMed] [Google Scholar]
  17. Stylianopoulou F., Herbert J., Soares M. B., Efstratiadis A. Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci U S A. 1988 Jan;85(1):141–145. doi: 10.1073/pnas.85.1.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tseng L. Y., Brown A. L., Yang Y. W., Romanus J. A., Orlowski C. C., Taylor T., Rechler M. M. The fetal rat binding protein for insulin-like growth factors is expressed in the choroid plexus and cerebrospinal fluid of adult rats. Mol Endocrinol. 1989 Oct;3(10):1559–1568. doi: 10.1210/mend-3-10-1559. [DOI] [PubMed] [Google Scholar]
  19. Unterman T. G., Glick R. P., Waites G. T., Bell S. C. Production of insulin-like growth factor-binding proteins by human central nervous system tumors. Cancer Res. 1991 Jun 1;51(11):3030–3036. [PubMed] [Google Scholar]
  20. Valentino K. L., Ocrant I., Rosenfeld R. G. Developmental expression of insulin-like growth factor-II receptor immunoreactivity in the rat central nervous system. Endocrinology. 1990 Feb;126(2):914–920. doi: 10.1210/endo-126-2-914. [DOI] [PubMed] [Google Scholar]
  21. Westphal M., Nausch H., Herrmann H. D. Cyst fluids of malignant human brain tumors contain substances that stimulate the growth of cultured human gliomas of various histological type. Neurosurgery. 1989 Aug;25(2):196–201. doi: 10.1097/00006123-198908000-00007. [DOI] [PubMed] [Google Scholar]
  22. Zumkeller W., Säf M., Rähn T., Hall K. Demonstration of insulin-like growth factors I, II and heterogeneous insulin-like growth factor binding proteins in the cyst fluid of patients with craniopharyngioma. Neuroendocrinology. 1991 Sep;54(3):196–201. doi: 10.1159/000125876. [DOI] [PubMed] [Google Scholar]
  23. Zumkeller W., Säf M., Rähn T. Insulin-like growth factor (IGF)-I, -II and IGF-binding proteins in the cyst fluid of a patient with astrocytoma. Childs Nerv Syst. 1993 Apr;9(2):100–103. doi: 10.1007/BF00305317. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES